[Translation] A randomized, blinded, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of BW-201 (Adj 2) in healthy adults aged 18 years and older
主要目的:
评价接种1剂RSV疫苗(BW-201 (Adj 2))后一个月(至D30)内的安全性和耐受性。
次要目的:
评价接种1剂RSV疫苗(BW-201 (Adj 2))的体液免疫反应。
评价接种1剂RSV疫苗(BW-201 (Adj 2))的细胞免疫反应。
评价接种1剂RSV疫苗(BW-201 (Adj 2))在试验随访期间(至M12)的安全性。
[Translation] Primary objectives:
To evaluate the safety and tolerability of RSV vaccine (BW-201 (Adj 2)) within one month (to D30) after 1 dose.
Secondary objectives:
To evaluate the humoral immune response to 1 dose of RSV vaccine (BW-201 (Adj 2)).
To evaluate the cellular immune response to 1 dose of RSV vaccine (BW-201 (Adj 2)).
To evaluate the safety of 1 dose of RSV vaccine (BW-201 (Adj 2)) during the follow-up period (to M12).